Clinical trials reimagined: Integrating community engagement and artificial intelligence

Area of Science:

• Clinical Research
• Biotechnology
• Health Equity

Background:

• The landscape of clinical research is rapidly evolving.
• There is a growing need for innovative approaches to enhance participant diversity and convenience.
• Addressing health disparities and building community trust are critical for equitable healthcare.

Purpose of the Study:

• To highlight visionary perspectives on the future of clinical research.
• To explore the impact of emerging technologies and strategies on clinical development.
• To underscore the convergence of innovation, inclusivity, and technology in therapeutic advancement.

Main Methods:

• Review of current trends and future directions in clinical research.
• Discussion of decentralized clinical trials (DCTs) and their benefits.
• Exploration of community engagement strategies for health equity.
• Examination of generative artificial intelligence (AI) applications in drug discovery and development.

Main Results:

• Decentralized clinical trials enhance participant diversity and convenience by bringing research into homes.
• Community engagement is crucial for addressing health disparities and fostering trust.
• Generative AI offers transformative potential for automating and personalizing drug discovery and clinical development.

Conclusions:

• The future of clinical research is shaped by innovation, inclusivity, and technology.
• Decentralized trials, community engagement, and AI are key drivers of accelerated therapeutic delivery.
• These transformative shifts promise more effective and accessible therapies for all populations.